Reaction

Haemoglobinuria reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,108 reports · 4 co-occurring drugs

As of the last recalculation, Haemoglobinuria appears in 1,108 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 706.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Eculizumab719706.2715.7
Ravulizumab1622.622.6
Deferasirox1812.913.0
Alteplase56.36.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.